Lately i’ve started to experience the signs of dry eye. Usually, it’s noticeable when I’m working at the computer, particularly when proofreading mivision, just ahead of going to print.

Dr Sartaj Sandhu is an experienced cataract and glaucoma surgeon who is actively involved in research and teaching. He is a visiting medical officer (glaucoma) at Royal Price Alfred Hospital and Practises at various Sydney locations.

“If we are leading the eye care world in our attitudes towards best-practice myopia management, is this being translated into discussions with parents and evidencebased prescribing?”

Immediately sequential bilateral cataract surgery (ISBCS) is a safe procedure, capable of reducing wait lists, according to a high-volume Canadian tertiary care centre.

People living with retinitis pigmentosa (RP) may one day benefit from a new drug being trialled in Australia.

A mobile app capable of early detection of glaucoma, diabetic retinopathy, and cataracts has been designed for use in parts of the world lacking easy access to healthcare.

Hundreds of new genes have been linked to a person’s risk of developing glaucoma, including key genetic targets that could, for the first time, pave the way for treatments that prevent the retinal damage that causes blindness.

For the first time, researchers have worked out the mechanism behind the way the brain regulates pupil size.

T cells guard the healthy human cornea from pathogens and inflammation, as opposed to dendritic cells, according to breakthrough findings from University of Melbourne researchers.

An international team of researchers, including from the University of Adelaide, has reported a technological breakthrough for optical coherence tomography (OCT), which could revolutionise applications in ophthalmology, dermatology, cardiology, and the early detection of cancer.

Tenpoint Therapeutics has launched with the backing of US$70 million, to be used to develop a regenerative medicine platform focussed on developing visionrestoring, engineered, cell-based therapeutics and in vivo reprogramming for degenerative ocular diseases.

Indigenous people from around Australia have aligned to advance our understanding of genomic medicine.

Biopharmaceutical company Apellis said there was “no indication that drug product or manufacturing issues” contributed to reported events of retinal vasculitis in United States patients treated with Syfovre (pegcetacoplan injection).

An entirely new class of drugs that can repair organ damage caused by degenerative diseases, rather than merely preventing further damage, is expected to change the drug landscape.

Missed health checks and reduced access to routine health care for people living with type 2 diabetes could be costing the Australian health system around AU$2.3B per annum, or $3,564 per person per annum, according to modelling from Diabetes Australia.

CooperVision’s New York global packaging and distribution centre has earned the prestigious LEED Silver certification for its environmentally conscious design and operation. The facility, which measures over 18,500m2 , processes and ships nearly one billion contact lenses each year to customers around the world.

Selective laser trabeculoplasty (SLT) has been proven to slow the progression of existing glaucoma disease by lowering pressure inside the eye.

Enrolments are being accepted for the Australian College of Optometry’s Advanced Certificate in Glaucoma (ACO-ACG) remote learning course.

Kodiak Sciences has scrapped its attempt at making an anti-VEFG candidate to rival Eylea.

Findings from a study examining the clinical validity of Melbourne Rapid Field (MRF) vision test, by comparing this technology with existing devices, have been presented as a Poster by Associate Professor George Kong at the World Glaucoma Congress 2023 (WGC23) in Rome.

With growing prevalence of dry eye disease in the community, a group of optometrists in Queensland has established the Dry Eye Society to support eye care professionals in delivering accurate, evidence-based care.

Micheal Yapp has joined Optometry Australia (OA) in a new role focussed on advancing the profession, scaling up collaborative care, and supporting optometrists to practise to full scope.

A large cohort study of more than 1.7 million patients found that intravitreal anti-VEGF injections were associated with an increase in the likelihood of systemic adverse events among patients with diabetic retinopathy (DR), a leading cause of visual loss among working-aged adults.

An at-home device for myopia control has been approved for sale in Australia.

The Royal Victorian Eye and Ear Hospital (RVEEH) has opened its new Acute Ophthalmology Service (AOS), equipped with 10 consulting rooms, strategically placed near the hospital’s emergency department (ED).

Opthea’s lead biologic drug candidate, OPT-302, has been renamed ‘sozinibercept’. The nonproprietary drug name was approved by the American Medical Association’s United States Adopted Names (USAN) Council, in consultation with the World Health Organization’s International Nonproprietary Names (INN) Expert Committee.

Bailey Nelson has relaunched its flagship store at Bondi Junction’s Westfield Shopping Centre, with a new fit-out incorporating three examination rooms.

An Australian eye care brand to help alleviate signs and symptoms of dry eye disease has been launched by three optometrists, Billy Chang, Jeremy Chan, and Kwang Cham.

The Tear Film and Ocular Surface Society (TFOS) recently published the conclusions and recommendations of its latest workshop report, A lifestyle epidemic: Ocular surface disease, in the April edition of The Ocular Surface journal.

When Dr Rolando Toyos started his own ophthalmology and aesthetics practice in the United States 25 years ago, he had big dreams. He still does.

Have you ever encouraged a patient to have an old frame refitted with new lenses? Have you incentivised them to do so with a discount?

In a comprehensive report of minimally invasive glaucoma devices that are currently available, sitting in the wings, and emerging, Dr Sartaj Sandhu reports that minimally invasive glaucoma surgery (MIGS) is anything but minimal.

miophtalmology products

Built on the concept of learning in new, different, and collaborative ways, Geneye 2023 presented a unique, immersive, and experiential conference. Dr Rogan Fraser explains.

There has been a rapid evolution of glaucoma surgery in the past two decades, leading to an ever-increasing array of treatment options for clinicians who treat glaucoma. Lowering intraocular pressure (IOP) to halt glaucoma progression remains the treatment aim for all surgeries. Innovations in glaucoma surgery aim to achieve this with less side effects and improved repeatability. Classical filtration surgery, however, is still the mainstay of surgical management owing to its efficacy in advanced glaucoma and long track record. Drs Aaron Wong and Ridia Lim look at developments in glaucoma surgery and review older surgical techniques that are still key in a glaucoma surgeon’s armamentarium.

In the ninth in a series of articles summarising the key findings of the BCLA CLEAR publication, a major review of the published evidence relating to all aspects of contact lens practice, Adjunct Associate Professor Alex Hui offers an overview of the section relating to contact lens technologies of the future.

The incidence of dry eye disease is on the rise, and we are increasingly aware of the significant impact it can have on a person’s quality of life. While some researchers are currently focussed on understanding more about the causes of dry eye (see the review of the Tear Film and Ocular Surface report on lifestyle factors in this issue), others are intent on finding new, more effective treatments.

To understand more about minimally invasive glaucoma surgery (MIGS), Dr Margaret Lam interviewed Sujan Hong, an optometrist and surgical glaucoma specialist for Alcon with expert knowledge on the Hydrus Microstent.

Increased steps – up to10,000 steps a day – is the panacea to a better, healthier, and longer life.

midry eye products

Just months into his career, Dr Shuwen Yu is already changing lives by providing thorough patient care.

Optometry Australia is looking at digital oppor tunities to build community, and to embrace the future of healthcare information systems, as Skye Cappuccio writes.

With a focus on myopia, dry eye disease, and the ocular surface, the British Contact Lens Association’s (BCLA) flagship conference in Manchester, in the United Kingdom, made a welcome post-COVID return. Excited delegates from around the globe, including Jessica Chi, gathered to hear the latest research from industryleading experts.

Struggling to find a way to strike a balance between keeping your frames stock fresh and avoiding excess inventory? mivision went looking for tips on this crucial aspect of business practice and found there’s no one right way.

So, you always thought you’d like to retire at age 65, and as you nudge 64, you figure you probably need to start getting all your ducks in a row. Well, you’re probably leaving it a little late. There’s quite a bit you should be doing a few years out to ensure your practice – the business that you’ve put years of blood, sweat, and tears into – will generate the maximum sale price when the time comes.

With the optical industry ever-changing, it can be hard to keep up with all the products available for our consumers, especially coming into the warmer months in Australia. In this article, Nicole Grasso refreshes and enriches your knowledge

mieyewear

mieyewear

When British designer Maximilian Davis took over the reins as creative director of Ferragamo in March 2022, he initially questioned whether he was ready for the challenge. Sixteen months on, the brand has a new lease of life, dressing men and women around the world

mifashion news

mievents

midiary